{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:50:22Z","timestamp":1793724622069,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12032-017-0945-y","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T09:09:37Z","timestamp":1491556177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset"],"prefix":"10.1007","volume":"34","author":[{"given":"Francesco","family":"Plotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Capriglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Montera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Luvero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonelli","family":"Gianina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Benedetti Panici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1158\/1055-9965.EPI-04-0871","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomark Prev. 2005;14:1132\u201342.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u201378.","journal-title":"Lancet"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"22","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;22:1404\u201311.","journal-title":"Lancet"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1586\/erm.09.39","volume":"9","author":"J Li","year":"2009","unstructured":"Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, et al. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn. 2009;9:555\u201366.","journal-title":"Expert Rev Mol Diagn"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1470-2045(10)70268-0","volume":"12","author":"I Jacobs","year":"2011","unstructured":"Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, et al. Sensitivity of transvaginal ultrasound for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12:38\u201348.","journal-title":"Lancet Oncol"},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/uog.1704","volume":"24","author":"R Smith-Bindman","year":"2004","unstructured":"Smith-Bindman R, Weiss E, Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol. 2004;24:558\u201365.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"945_CR8","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","volume":"35","author":"R Angioli","year":"2014","unstructured":"Angioli R, Capriglione S, Aloisi A, Guzzo F, Luvero D, Miranda A, Damiani P, Montera R, Terranova C, Plotti F. Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? Tumour Biol. 2014;35(7):7009\u201315.","journal-title":"Tumour Biol"},{"issue":"6","key":"945_CR9","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s13277-012-0471-7","volume":"33","author":"F Plotti","year":"2012","unstructured":"Plotti F, Capriglione S, Terranova C, Montera R, Aloisi A, Damiani P, Muzii L, Scaletta G, Benedetti-Panici P, Angioli R. Does HE4 have a role as biomarker in the recurrence of ovarian cancer? Tumour Biol. 2012;33(6):2117\u201323.","journal-title":"Tumour Biol"},{"issue":"3","key":"945_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ygyno.2012.11.040","volume":"128","author":"R Angioli","year":"2013","unstructured":"Angioli R, Plotti F, Capriglione S, et al. Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol. 2013;128(3):579\u201383.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"945_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ygyno.2012.11.023","volume":"128","author":"EI Braicu","year":"2013","unstructured":"Braicu EI, Fotopoulou C, Van Gorp T, et al. Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study. Gynecol Oncol. 2013;128(2):245\u201351.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"945_CR12","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1245\/s10434-015-4534-z","volume":"22","author":"R Angioli","year":"2015","unstructured":"Angioli R, Capriglione S, Aloisi A, Ricciardi R, Scaletta G, Lopez S, Miranda A, Di Pinto A, Terranova C, Plotti F. A predictive score for secondary cytoreductive surgery in recurrent ovarian cancer (SeC-Score): A single-centre, controlled study for preoperative patient selection. Ann Surg Oncol. 2015;22(13):4217\u201323. doi: 10.1245\/s10434-015-4534-z .","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"945_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00404-016-4181-z","volume":"294","author":"R Angioli","year":"2015","unstructured":"Angioli R, Plotti F, Capriglione S, Scaletta G, Dugo N, Aloisi A, Piccolo CL, Del Vescovo R, Terranova C, Zobel BB. Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers. Arch Gynecol Obstet. 2016;294(6):1291\u20138.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"945_CR14","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1007\/s13277-015-4324-z","volume":"37","author":"R Angioli","year":"2016","unstructured":"Angioli R, Capriglione S, Scaletta G, Aloisi A, Miranda A, De Cicco Nardone C, Terranova C, Plotti F. The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program. Tumour Biol. 2016;37(4):4973\u20138.","journal-title":"Tumour Biol"},{"issue":"6","key":"945_CR15","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1007\/s13277-015-3049-3","volume":"36","author":"S Capriglione","year":"2015","unstructured":"Capriglione S, Plotti F, Miranda A, Ricciardi R, Scaletta G, Aloisi A, Guzzo F, Montera R, Angioli R. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study. Tumour Biol. 2015;36(6):4151\u20136.","journal-title":"Tumour Biol"},{"issue":"2","key":"945_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13277-013-1190-4","volume":"35","author":"R Angioli","year":"2014","unstructured":"Angioli R, Miranda A, Aloisi A, Montera R, Capriglione S, De Cicco Nardone C, Terranova C, Plotti F. A critical review on HE4 performance in endometrial cancer: where are we now? Tumour Biol. 2014;35(2):881\u20137.","journal-title":"Tumour Biol"},{"issue":"20","key":"945_CR17","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-13-1376","volume":"19","author":"R Angioli","year":"2013","unstructured":"Angioli R, Capriglione S, Aloisi A, Luvero D, Caf\u00e0 EV, Dugo N, Montera R, De Cicco Nardone C, Terranova C, Plotti F. REM (risk of endometrial malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy. Clin Cancer Res. 2013;19(20):5733\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"945_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s13277-012-0583-0","volume":"34","author":"R Angioli","year":"2013","unstructured":"Angioli R, Plotti F, Capriglione S, Montera R, Damiani P, Ricciardi R, Aloisi A, Luvero D, Caf\u00e0 EV, Dugo N, Angelucci M, Benedetti-Panici P. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. Tumour Biol. 2013;34(1):571\u20136.","journal-title":"Tumour Biol"},{"key":"945_CR19","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/bjc.2011.109","volume":"104","author":"E Bignotti","year":"2011","unstructured":"Bignotti E, Ragnoli M, Zanotti L, Calza S, Falchetti M, Lonardi S, et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. Br J Cancer. 2011;104:1418\u201325.","journal-title":"Br J Cancer"},{"issue":"15","key":"945_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12885-015-1028-0","volume":"6","author":"DJ Brennan","year":"2015","unstructured":"Brennan DJ, Hackethal A, Mann KP, Mutz-Dehbalaie I, Fiegl H, Marth C, Obermair A. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance. BMC Cancer. 2015;6(15):33.","journal-title":"BMC Cancer"},{"issue":"7","key":"945_CR21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IGC.0b013e3182229ad8","volume":"21","author":"RG Moore","year":"2011","unstructured":"Moore RG, Miller CM, Brown AK, Robison K, Steinhoff M, Lambert-Messerlian G. Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus. Int J Gynecol Cancer. 2011;21(7):1185\u201390.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"945_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ygyno.2011.10.025","volume":"124","author":"E Kalogera","year":"2012","unstructured":"Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, et al. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecol Oncol. 2012;124(2):270\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"945_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ygyno.2012.04.022","volume":"126","author":"I Mutz-Dehbalaie","year":"2012","unstructured":"Mutz-Dehbalaie I, Egle D, Fessler S, Hubalek M, Fiegl H, Marth C, et al. HE4 is an independent prognostic marker in endometrial cancer patients. Gynecol Oncol. 2012;126(2):186\u201391.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"945_CR24","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1515\/cclm-2011-0757","volume":"50","author":"L Zanotti","year":"2012","unstructured":"Zanotti L, Bignotti E, Calza S, Bandiera E, Ruggeri G, Galli C, et al. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome. Clin Chem Lab Med. 2012;50(12):2189\u201398.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"945_CR25","doi-asserted-by":"publisher","first-page":"142.el-6","DOI":"10.1016\/j.ajog.2013.04.014","volume":"209","author":"SK Saarelainen","year":"2013","unstructured":"Saarelainen SK, Peltonen N, Lehtim\u00e4ki T, Perheentupa A, Vuento MH, M\u00e4enp\u00e4\u00e4 JU. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Am J Obstet Gynecol. 2013;209(2):142.el-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"945_CR26","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s13277-013-0814-z","volume":"34","author":"B Omer","year":"2013","unstructured":"Omer B, Genc S, Takmaz O, Dirican A, Kusku-Kiraz Z, Berkman S, Gurdol F. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients. Tumor Biol. 2013;34(5):2645\u201350.","journal-title":"Tumor Biol"},{"key":"945_CR27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1515\/cclm-2012-0373","volume":"50","author":"M Plebani","year":"2012","unstructured":"Plebani M, HE4 Study Group. HE4 in gynecological cancers: report of a European investigators and experts meeting. Clin Chem Lab Med. 2012;50:2127\u201336.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"945_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14737140.2017.1266263","volume":"17","author":"S Capriglione","year":"2017","unstructured":"Capriglione S, Plotti F, Miranda A, Lopez S, Scaletta G, Moncelli M, Luvero D, De Cicco Nardone C, Terranova C, Montera R, Angioli R. Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4. Expert Rev Anticancer Ther. 2017;17(1):9\u201318.","journal-title":"Expert Rev Anticancer Ther"},{"key":"945_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2012.06.080","volume":"207","author":"S Bendifallah","year":"2012","unstructured":"Bendifallah S, Genin AS, Naoura I, Chabbert Buffet N, Clavel Chapelon F, Haddad B, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"945_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2012.04.035","volume":"125","author":"CS Awtrey","year":"2012","unstructured":"Awtrey CS. Nomograms for predicting endometrial cancer recurrence. Gynecol Oncol. 2012;125:513\u20134.","journal-title":"Gynecol Oncol"},{"key":"945_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ygyno.2009.11.027","volume":"116","author":"NR Abu-Rustum","year":"2010","unstructured":"Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, et al. A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol. 2010;116:399\u2013403.","journal-title":"Gynecol Oncol"},{"key":"945_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/uog.13205","volume":"43","author":"M Dueholm","year":"2014","unstructured":"Dueholm M, M\u00f8ller C, Rydbjerg S, Hansen ES, Ortoft G. An ultrasound algorithm for identification of endometrial cancer. Ultrasound Obstet Gynecol. 2014;43:557\u201368.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"945_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/uog.13352","volume":"44","author":"R Angioli","year":"2014","unstructured":"Angioli R, Aloisi A, Capriglione S, Plotti F. Numquam ponenda est pluralitas sine necessitate? Ultrasound Obstet Gynecol. 2014;44(3):372\u20133.","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-017-0945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-017-0945-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-017-0945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:19:34Z","timestamp":1750195174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-017-0945-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s12032-017-0945-y","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"article-number":"82"}}